Saturday, July 6, 2024
HomeTagsHoloclara

Holoclara

Holoclara Announces $16 Million Series A Financing to Advance a Breakthrough Class of Worm-Derived Therapies for Allergic and Autoimmune Disease

Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergies and autoimmune disorders, announced the completion of an oversubscribed $16 million Series...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics